Federal award
EXELAN PHARMACEUTICALS INC
SPM2D014DN003
Contract vehicle (IDV)IDV: ceiling is not spending
Obligated and Ceiling
- Obligated (net)
- $0.00
- Vehicle ceiling (not spending)
- $0.01
- Current value
- —
- Gross positive obligations
- $0.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- EXELAN PHARMACEUTICALS INC · FYZXNHSQTMG8
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- CIPLA USA INC. · MVGMCHRNA7M8
- Awarding agency
- Department of Defense · sub-agency 97AS · office SPM2D0
- Funding agency
- Department of Defense · sub-agency 97AS
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325411 · MEDICINAL AND BOTANICAL MANUFACTURING
- PIID
- SPM2D014DN003
- Award type code
- B
- Actions
- 6 · Nov 5, 2013 to Jul 18, 2018
- Why it is listed
- contract vehicle (IDV)
Action History6
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jul 18, 2018 | FY2018 | P00105 | M | $0.00 | — |
| Oct 31, 2017 | FY2018 | P00104 | G | $0.00 | — |
| Nov 3, 2016 | FY2017 | P00103 | G | $0.00 | — |
| Nov 2, 2015 | FY2016 | P00102 | G | $0.00 | — |
| Nov 4, 2014 | FY2015 | P00101 | G | $0.00 | — |
| Nov 5, 2013 | FY2014 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.